Literature DB >> 17206425

Imaging of Budd-Chiari syndrome.

O Buckley1, J O' Brien, A Snow, H Stunell, I Lyburn, P L Munk, W C Torreggiani.   

Abstract

Budd-Chiari syndrome occurs when venous outflow from the liver is obstructed. The obstruction may occur at any point from the hepatic venules to the left atrium. The syndrome most often occurs in patients with underlying thrombotic disorders such as polycythemia rubra vera, paroxysmal nocturnal hemoglobinuria and pregnancy. It may also occur secondary to a variety of tumours, chronic inflammatory diseases and infections. Imaging plays an important role both in establishing the diagnosis of Budd-Chiari syndrome as well as evaluating for underlying causes and complications such as portal hypertension. In this review article, we discuss the role of modern imaging in the evaluation of Budd-Chiari syndrome.

Entities:  

Mesh:

Year:  2007        PMID: 17206425     DOI: 10.1007/s00330-006-0537-2

Source DB:  PubMed          Journal:  Eur Radiol        ISSN: 0938-7994            Impact factor:   7.034


  31 in total

1.  Imaging findings in Budd-Chiari syndrome.

Authors:  M A McKusick
Journal:  Liver Transpl       Date:  2001-08       Impact factor: 5.799

2.  Long-term effect of treatment of acute Budd-Chiari syndrome with a transjugular intrahepatic portosytemic shunt.

Authors:  Hans Blokzijl; Robert J de Knegt
Journal:  Hepatology       Date:  2002-06       Impact factor: 17.425

Review 3.  The diagnosis and management of the Budd-Chiari syndrome: consensus and controversies.

Authors:  Dominique-Charles Valla
Journal:  Hepatology       Date:  2003-10       Impact factor: 17.425

Review 4.  The Budd-Chiari syndrome.

Authors:  K V Narayanan Menon; Vijay Shah; Patrick S Kamath
Journal:  N Engl J Med       Date:  2004-02-05       Impact factor: 91.245

5.  Percutaneous transhepatic venoplasty: an alternative treatment for Budd-Chiari syndrome.

Authors:  Kadir Bahar; Selim Karayalçin; Muhsin Kaya; Hülya Cetinkaya; Hakan Bozkaya; Cihan Yurdaydin
Journal:  Turk J Gastroenterol       Date:  2002-06       Impact factor: 1.852

6.  Hepatic changes in benign obstruction of the hepatic inferior vena cava: CT findings.

Authors:  T K Kim; J W Chung; J K Han; A Y Kim; J H Park; B I Choi
Journal:  AJR Am J Roentgenol       Date:  1999-11       Impact factor: 3.959

7.  Subacute Budd-Chiari syndrome associated with polycythemia vera and factor V Leiden mutation.

Authors:  S Simsek; R V Verheesen; E B Haagsma; J Lourens
Journal:  Neth J Med       Date:  2000-08       Impact factor: 1.422

8.  Budd-Chiari syndrome in a patient with factor V Leiden--successful treatment by TIPSS placement followed by liver transplantation.

Authors:  W Avenhaus; H Ullerich; J Menzel; E C Foerster; K Hengst; W Domschke
Journal:  Z Gastroenterol       Date:  1999-04       Impact factor: 2.000

9.  Does hepatic vein outflow obstruction contribute to the pathogenesis of hepatocellular carcinoma?

Authors:  Y Bayraktar; T Egesel; F Sağlam; F Balkanci; D H Van Thiel
Journal:  J Clin Gastroenterol       Date:  1998-07       Impact factor: 3.062

10.  Budd-Chiari syndrome: diagnosis with three-dimensional contrast-enhanced magnetic resonance angiography.

Authors:  Jiang Lin; Xiao-Hai Chen; Kang-Rong Zhou; Zu-Wang Chen; Jian-Hua Wang; Zhi-Ping Yan; Ping Wang
Journal:  World J Gastroenterol       Date:  2003-10       Impact factor: 5.742

View more
  11 in total

1.  Studies on Budd-chiari syndrome complicated with hepatocellular carcinoma: most patients without inferior vena cava obstruction.

Authors:  Xiaowei Dang; Luhao Li; Suxin Li; Yafei Wang; Hai Li; Shaokai Xu; Peiqin Xu
Journal:  Int J Clin Exp Med       Date:  2015-06-15

2.  Aetiological factors of Budd-Chiari syndrome in Algeria.

Authors:  Nawel Afredj; Nawal Guessab; Abdelbasset Nani; Sid Ahmed Faraoun; Ibtissem Ouled Cheikh; Rafik Kerbouche; Djouhar Hannoun; Zine Charef Amir; Hayet Ait Kaci; Kamel Bentabak; Aurélie Plessier; Dominique-Charles Valla; Valerie Cazals-Hatem; Marie-Hélène Denninger; Tadjeddine Boucekkine; Nabil Debzi
Journal:  World J Hepatol       Date:  2015-04-28

3.  The role of intravascular intervention in the management of Budd-Chiari syndrome.

Authors:  Hui Xue; Ying-Chao Li; Pramod Shakya; Muna Palikhe; Rajiv Kumar Jha
Journal:  Dig Dis Sci       Date:  2009-12-25       Impact factor: 3.199

4.  Budd-Chiari syndrome, mediastinal mass and recalcitrant leg ulcers, an unlikely trio.

Authors:  Alfonso Tafur; Waldemar Wysokinski; Terri Vrtiska; Robert McBane
Journal:  J Thromb Thrombolysis       Date:  2010-08       Impact factor: 2.300

Review 5.  Budd-Chiari syndrome: imaging review.

Authors:  Varun Bansal; Pankaj Gupta; Saroj Sinha; Narender Dhaka; Naveen Kalra; Rajesh Vijayvergiya; Usha Dutta; Rakesh Kochhar
Journal:  Br J Radiol       Date:  2018-07-24       Impact factor: 3.039

Review 6.  Budd-Chiari syndrome.

Authors:  Pieter Martens; Frederik Nevens
Journal:  United European Gastroenterol J       Date:  2015-12       Impact factor: 4.623

7.  Initial imaging analysis of Budd-Chiari syndrome in Henan province of China: most cases have combined inferior vena cava and hepatic veins involvement.

Authors:  Pengli Zhou; Jianzhuang Ren; Xinwei Han; Gang Wu; Wenguang Zhang; Pengxu Ding; Yonghua Bi
Journal:  PLoS One       Date:  2014-01-08       Impact factor: 3.240

8.  Diagnostic performance of Contrast-enhanced CT in Pyrrolizidine Alkaloids-induced Hepatic Sinusoidal Obstructive Syndrome.

Authors:  Xuefeng Kan; Jin Ye; Xinxin Rong; Zhiwen Lu; Xin Li; Yong Wang; Ling Yang; Keshu Xu; Yuhu Song; Xiaohua Hou
Journal:  Sci Rep       Date:  2016-11-29       Impact factor: 4.379

9.  The antiphospholipid antibody syndrome: a case report.

Authors:  Henry Namme Luma; Marie-Solange Doualla; Elvis Temfack; Servais Albert Fiacre Eloumou Bagnaka; Emmanuella Wankie Mankaa; Dobgima Fofung
Journal:  Int Med Case Rep J       Date:  2012-10-05

Review 10.  Imaging Diagnosis of Splanchnic Venous Thrombosis.

Authors:  S Rajesh; Amar Mukund; Ankur Arora
Journal:  Gastroenterol Res Pract       Date:  2015-10-12       Impact factor: 2.260

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.